Chromatography refolding of recombinant alpha-fetoprotein for high refolding productivity and intensified bioprocessing

Alpha-fetoprotein (AFP) is a commercially valuable biopharmaceutical candidate for autoimmune indications. Transgenically-derived recombinant AFP has recently successfully completed a Phase Two clinical trial study for rheumatoid arthritis indications at Merrimack Pharmaceuticals (Cambridge, MA, USA...

Full description

Saved in:
Bibliographic Details
Main Author: Chen, Yu
Other Authors: Susanna Leong Su Jan
Format: Theses and Dissertations
Language:English
Published: 2011
Subjects:
Online Access:https://hdl.handle.net/10356/43987
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-43987
record_format dspace
spelling sg-ntu-dr.10356-439872023-03-03T16:02:41Z Chromatography refolding of recombinant alpha-fetoprotein for high refolding productivity and intensified bioprocessing Chen, Yu Susanna Leong Su Jan School of Chemical and Biomedical Engineering DRNTU::Engineering::Chemical engineering::Biotechnological production Alpha-fetoprotein (AFP) is a commercially valuable biopharmaceutical candidate for autoimmune indications. Transgenically-derived recombinant AFP has recently successfully completed a Phase Two clinical trial study for rheumatoid arthritis indications at Merrimack Pharmaceuticals (Cambridge, MA, USA). The launch of this protein on market shelves in the future will subsequently demand cheaper second-generation product when product patent expires, thus necessitating new processes that can reduce product cost. The production of AFP as inclusion bodies (IBs) in Escherichia coli (E. coli) is advantageous for process-scale commercial manufacture due to speed, simplicity and cost reasons but conversion of the inactive protein aggregate into biologically active protein requires an efficient refolding step. The use of dilution refolding in previously reported recombinant human AFP (rhAFP) laboratory processes has resulted in low refolding yields, which negatively impacts the overall process yield and productivity. A superior refolding and bioprocessing route is clearly needed to facilitate efficient and rapid product delivery to market, if a commercial process for rhAFP is to be possible. In this thesis, chromatography refolding was researched to address the poor refolding performance or rhAFP in previous ‘dilution refolding’-based rhAFP processes. DOCTOR OF PHILOSOPHY (SCBE) 2011-05-18T04:18:44Z 2011-05-18T04:18:44Z 2011 2011 Thesis Chen, Y. (2011). Chromatography refolding of recombinant alpha-fetoprotein for high refolding productivity and intensified bioprocessing. Doctoral thesis, Nanyang Technological University, Singapore. https://hdl.handle.net/10356/43987 10.32657/10356/43987 en 185 p. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic DRNTU::Engineering::Chemical engineering::Biotechnological production
spellingShingle DRNTU::Engineering::Chemical engineering::Biotechnological production
Chen, Yu
Chromatography refolding of recombinant alpha-fetoprotein for high refolding productivity and intensified bioprocessing
description Alpha-fetoprotein (AFP) is a commercially valuable biopharmaceutical candidate for autoimmune indications. Transgenically-derived recombinant AFP has recently successfully completed a Phase Two clinical trial study for rheumatoid arthritis indications at Merrimack Pharmaceuticals (Cambridge, MA, USA). The launch of this protein on market shelves in the future will subsequently demand cheaper second-generation product when product patent expires, thus necessitating new processes that can reduce product cost. The production of AFP as inclusion bodies (IBs) in Escherichia coli (E. coli) is advantageous for process-scale commercial manufacture due to speed, simplicity and cost reasons but conversion of the inactive protein aggregate into biologically active protein requires an efficient refolding step. The use of dilution refolding in previously reported recombinant human AFP (rhAFP) laboratory processes has resulted in low refolding yields, which negatively impacts the overall process yield and productivity. A superior refolding and bioprocessing route is clearly needed to facilitate efficient and rapid product delivery to market, if a commercial process for rhAFP is to be possible. In this thesis, chromatography refolding was researched to address the poor refolding performance or rhAFP in previous ‘dilution refolding’-based rhAFP processes.
author2 Susanna Leong Su Jan
author_facet Susanna Leong Su Jan
Chen, Yu
format Theses and Dissertations
author Chen, Yu
author_sort Chen, Yu
title Chromatography refolding of recombinant alpha-fetoprotein for high refolding productivity and intensified bioprocessing
title_short Chromatography refolding of recombinant alpha-fetoprotein for high refolding productivity and intensified bioprocessing
title_full Chromatography refolding of recombinant alpha-fetoprotein for high refolding productivity and intensified bioprocessing
title_fullStr Chromatography refolding of recombinant alpha-fetoprotein for high refolding productivity and intensified bioprocessing
title_full_unstemmed Chromatography refolding of recombinant alpha-fetoprotein for high refolding productivity and intensified bioprocessing
title_sort chromatography refolding of recombinant alpha-fetoprotein for high refolding productivity and intensified bioprocessing
publishDate 2011
url https://hdl.handle.net/10356/43987
_version_ 1759855647488212992